Tudor Investment Corp’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-33,559
Closed -$83K 2272
2021
Q3
$83K Buy
+33,559
New +$83K ﹤0.01% 1473
2020
Q4
Sell
-19,830
Closed -$62K 1759
2020
Q3
$62K Sell
19,830
-33,471
-63% -$105K ﹤0.01% 1195
2020
Q2
$155K Sell
53,301
-26,123
-33% -$76K 0.01% 1046
2020
Q1
$224K Sell
79,424
-34,310
-30% -$96.8K 0.02% 789
2019
Q4
$369K Sell
113,734
-18,043
-14% -$58.5K 0.02% 808
2019
Q3
$285K Buy
+131,777
New +$285K 0.01% 861
2019
Q2
Sell
-34,938
Closed -$130K 1470
2019
Q1
$130K Buy
34,938
+22,593
+183% +$84.1K 0.01% 1022
2018
Q4
$36K Sell
12,345
-598
-5% -$1.74K ﹤0.01% 953
2018
Q3
$34K Buy
+12,943
New +$34K ﹤0.01% 1038
2018
Q2
Sell
-21,351
Closed -$63K 1345
2018
Q1
$63K Buy
+21,351
New +$63K ﹤0.01% 928
2017
Q2
Sell
-213,284
Closed -$484K 1605
2017
Q1
$484K Sell
213,284
-79,116
-27% -$180K 0.01% 700
2016
Q4
$620K Buy
292,400
+202,100
+224% +$429K 0.02% 589
2016
Q3
$303K Buy
+90,300
New +$303K 0.01% 995
2016
Q2
Sell
-87,100
Closed -$290K 1851
2016
Q1
$290K Sell
87,100
-38,800
-31% -$129K 0.01% 1095
2015
Q4
$446K Buy
125,900
+81,000
+180% +$287K 0.01% 845
2015
Q3
$226K Sell
44,900
-42,100
-48% -$212K 0.01% 1200
2015
Q2
$559K Sell
87,000
-31,200
-26% -$200K 0.02% 676
2015
Q1
$832K Buy
118,200
+49,900
+73% +$351K 0.03% 447
2014
Q4
$527K Sell
68,300
-57,600
-46% -$444K 0.02% 677
2014
Q3
$940K Buy
125,900
+75,300
+149% +$562K 0.03% 312
2014
Q2
$490K Sell
50,600
-31,800
-39% -$308K 0.02% 539
2014
Q1
$685K Sell
82,400
-12,000
-13% -$99.8K 0.03% 348
2013
Q4
$797K Buy
94,400
+65,500
+227% +$553K 0.04% 290
2013
Q3
$230K Sell
28,900
-37,200
-56% -$296K 0.01% 683
2013
Q2
$510K Buy
+66,100
New +$510K 0.04% 314